Amphastar Pharmaceuticals (AMPH)
(Delayed Data from NSDQ)
$47.57 USD
+1.28 (2.77%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $47.56 -0.01 (-0.02%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth D Momentum B VGM
Amphastar Pharmaceuticals (AMPH) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$59.80 | $70.00 | $48.00 | 29.19% |
Price Target
Based on short-term price targets offered by five analysts, the average price target for Amphastar Pharmaceuticals comes to $59.80. The forecasts range from a low of $48.00 to a high of $70.00. The average price target represents an increase of 29.19% from the last closing price of $46.29.
Analyst Price Targets (5 )
Broker Rating
Amphastar Pharmaceuticals currently has an average brokerage recommendation (ABR) of 1.67 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by six brokerage firms. The current ABR compares to an ABR of 1.67 a month ago based on six recommendations.
Of the six recommendations deriving the current ABR, four are Strong Buy, representing 66.67% of all recommendations. A month ago, Strong Buy represented 66.67%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 4 | 4 | 4 | 5 | 5 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 2 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.67 | 1.67 | 1.67 | 1.57 | 1.57 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/12/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
8/8/2024 | Needham & Company | Serge Belanger | Hold | Hold |
8/7/2024 | Capital One Securities | Timothy Chiang | Strong Buy | Strong Buy |
6/26/2024 | Piper Sandler | David Amsellem | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.67 |
ABR (Last week) | 1.67 |
# of Recs in ABR | 6 |
Average Target Price | $59.80 |
LT Growth Rate | 14.20% |
Industry | Medical - Generic Drugs |
Industry Rank by ABR | 59 of 252 |
Current Quarter EPS Est: | 1.03 |
AMPH FAQs
Amphastar Pharmaceuticals, Inc. (AMPH) currently has an average brokerage recommendation (ABR) of 1.67 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 6 brokerage firms.
The average price target for Amphastar Pharmaceuticals, Inc. (AMPH) is $59.80. The current on short-term price targets is based on 5 reports.
The forecasts for Amphastar Pharmaceuticals, Inc. (AMPH) range from a low of $48 to a high of $70. The average price target represents a increase of $25.71 from the last closing price of $47.57.
The current UPSIDE for Amphastar Pharmaceuticals, Inc. (AMPH) is 25.71%
Based on short-term price targets offered by five analysts, the average price target for Amphastar Pharmaceuticals comes to $59.80. The forecasts range from a low of $48.00 to a high of $70.00. The average price target represents an increase of 29.19% from the last closing price of $46.29.